425 related articles for article (PubMed ID: 8396632)
21. Lack of specific binding of bradykinin and D-Arg [Hyp3, Thi5, D-Tic, Oic8] bradykinin in membranes from rat heart.
Albus U; Gao X; Greenbaum LM
Agents Actions Suppl; 1992; 38 ( Pt 3)():73-9. PubMed ID: 1334361
[TBL] [Abstract][Full Text] [Related]
22. DesArg9-D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a potent bradykinin B1 receptor antagonist.
Wirth K; Breipohl G; Stechl J; Knolle J; Henke S; Schölkens B
Eur J Pharmacol; 1991 Nov; 205(2):217-8. PubMed ID: 1667388
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of bradykinin-induced contraction of the guinea-pig gallbladder in vitro.
Cabrini DA; Silva AM; Calixto JB
Br J Pharmacol; 1995 Apr; 114(8):1549-56. PubMed ID: 7599922
[TBL] [Abstract][Full Text] [Related]
24. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
25. Bradykinin receptors of cerebral microvessels stimulate phosphoinositide turnover.
Homayoun P; Harik SI
J Cereb Blood Flow Metab; 1991 Jul; 11(4):557-66. PubMed ID: 1646827
[TBL] [Abstract][Full Text] [Related]
26. Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea, and are blocked by HOE 140.
Field JL; Hall JM; Morton IK
Br J Pharmacol; 1992 Feb; 105(2):293-6. PubMed ID: 1313723
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a pulmonary B3 bradykinin receptor.
Farmer SG; Burch RM; Meeker SA; Wilkins DE
Mol Pharmacol; 1989 Jul; 36(1):1-8. PubMed ID: 2546044
[TBL] [Abstract][Full Text] [Related]
28. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.
Farmer SG; Burch RM; Kyle DJ; Martin JA; Meeker SN; Togo J
Br J Pharmacol; 1991 Apr; 102(4):785-7. PubMed ID: 1649657
[TBL] [Abstract][Full Text] [Related]
29. The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.
Sharif NA; Whiting RL
Neurochem Res; 1993 Dec; 18(12):1313-20. PubMed ID: 8272196
[TBL] [Abstract][Full Text] [Related]
30. Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor.
Saha JK; Sengupta JN; Goyal RK
J Pharmacol Exp Ther; 1991 Oct; 259(1):265-73. PubMed ID: 1656023
[TBL] [Abstract][Full Text] [Related]
31. 125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Agents Actions Suppl; 1992; 38 ( Pt 1)():526-39. PubMed ID: 1334630
[TBL] [Abstract][Full Text] [Related]
32. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells.
Sharif NA; Xu SX
Exp Eye Res; 1996 Dec; 63(6):631-7. PubMed ID: 9068370
[TBL] [Abstract][Full Text] [Related]
34. S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
Félétou M; Robineau P; Lonchampt M; Bonnardel E; Thurieau C; Fauchère JL; Widdowson P; Mahieu JP; Serkiz B; Volland JP
J Pharmacol Exp Ther; 1995 Jun; 273(3):1071-7. PubMed ID: 7791077
[TBL] [Abstract][Full Text] [Related]
35. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
36. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
37. Bradykinin-stimulated phosphoinositide metabolism in cultured canine tracheal smooth muscle cells.
Yang CM; Hsia HC; Chou SP; Ong R; Hsieh JT; Luo SF
Br J Pharmacol; 1994 Jan; 111(1):21-8. PubMed ID: 8012698
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.
Pruneau D; Luccarini JM; Defrêne E; Paquet JL; Bélichard P
Br J Pharmacol; 1995 Oct; 116(3):2106-12. PubMed ID: 8640352
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin stimulation of phosphoinositide hydrolysis in guinea-pig ileum longitudinal muscle.
Ransom RW; Goodman CB; Young GS
Br J Pharmacol; 1992 Apr; 105(4):919-24. PubMed ID: 1324057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
